Articles producció científica> Ciències Mèdiques Bàsiques

Multilocus phylogeny and antifungal susceptibility of Aspergillus section Circumdati from clinical samples and description of A. pseudosclerotiorum sp. nov.

  • Dades identificatives

    Identificador: imarina:5130787
    Autors:
    Siqueira J., Sutton D., Gené J., García D., Wiederhold N., Peterson S., Guarro J.
    Resum:
    A multilocus phylogenetic study was carried out to assess species identity of a set of 34 clinical isolates from Aspergillus section Circumdati from the USA, and to determine their in vitro antifungal susceptibility against eight antifungal drugs. The genetic markers used were ITS, BenA, CaM and RPB2, and the drugs tested were amphotericin B, itraconazole, posaconazole, voriconazole, anidulafungin, caspofungin, micafungin, and terbinafine. The most common species sampled was A. westerdijkiae (29.4%), followed by a novel species, which was described here as A. pseudosclerotiorum (23.5%). Other species identified were A. sclerotiorum (17.6%), A. ochraceus (8.8%), A. subramanianii (8.8%), and A. insulicola and A. ochraceopetaliformis with two isolates (5.9%) each. The drugs that showed the most potent activity were caspofungin, micafungin, and terbinafine, while amphotericin B showed the least activity. Copyright 2017 American Society for Microbiology.
  • Altres:

    Autor segons l'article: Siqueira J., Sutton D., Gené J., García D., Wiederhold N., Peterson S., Guarro J.
    Departament: Ciències Mèdiques Bàsiques
    Autor/s de la URV: García Sánchez, Dania / Gené Díaz, Josepa / Guarro Artigas, Josep / ZEN SIQUEIRA, JOAO PAULO
    Paraules clau: Taxonomy Phenotypic identification Molecular phylogeny Molecular identification Clinical isolates Circumdati section Aspergillus section circumdati Aspergillus Antifungal susceptibility
    Resum: A multilocus phylogenetic study was carried out to assess species identity of a set of 34 clinical isolates from Aspergillus section Circumdati from the USA, and to determine their in vitro antifungal susceptibility against eight antifungal drugs. The genetic markers used were ITS, BenA, CaM and RPB2, and the drugs tested were amphotericin B, itraconazole, posaconazole, voriconazole, anidulafungin, caspofungin, micafungin, and terbinafine. The most common species sampled was A. westerdijkiae (29.4%), followed by a novel species, which was described here as A. pseudosclerotiorum (23.5%). Other species identified were A. sclerotiorum (17.6%), A. ochraceus (8.8%), A. subramanianii (8.8%), and A. insulicola and A. ochraceopetaliformis with two isolates (5.9%) each. The drugs that showed the most potent activity were caspofungin, micafungin, and terbinafine, while amphotericin B showed the least activity. Copyright 2017 American Society for Microbiology.
    Àrees temàtiques: Zootecnia / recursos pesqueiros Saúde coletiva Química Odontología Microbiology (medical) Microbiology Medicina veterinaria Medicina iii Medicina ii Medicina i Materiais Interdisciplinar Farmacia Ensino Engenharias ii Enfermagem Ciências biológicas iii Ciências biológicas ii Ciências biológicas i Ciências ambientais Ciência de alimentos Ciência da computação Biotecnología Biodiversidade
    Accès a la llicència d'ús: https://creativecommons.org/licenses/by/3.0/es/
    ISSN: 00951137
    Adreça de correu electrònic de l'autor: dania.garcias@urv.cat josepa.gene@urv.cat
    Identificador de l'autor: 0000-0003-2397-1646 0000-0001-6195-9299
    Data d'alta del registre: 2024-09-07
    Versió de l'article dipositat: info:eu-repo/semantics/acceptedVersion
    Enllaç font original: https://jcm.asm.org/content/55/3/947
    URL Document de llicència: https://repositori.urv.cat/ca/proteccio-de-dades/
    Referència a l'article segons font original: Journal Of Clinical Microbiology. 55 (3): 947-958
    Referència de l'ítem segons les normes APA: Siqueira J., Sutton D., Gené J., García D., Wiederhold N., Peterson S., Guarro J. (2017). Multilocus phylogeny and antifungal susceptibility of Aspergillus section Circumdati from clinical samples and description of A. pseudosclerotiorum sp. nov.. Journal Of Clinical Microbiology, 55(3), 947-958. DOI: 10.1128/JCM.02012-16
    DOI de l'article: 10.1128/JCM.02012-16
    Entitat: Universitat Rovira i Virgili
    Any de publicació de la revista: 2017
    Tipus de publicació: Journal Publications
  • Paraules clau:

    Microbiology,Microbiology (Medical)
    Taxonomy
    Phenotypic identification
    Molecular phylogeny
    Molecular identification
    Clinical isolates
    Circumdati section
    Aspergillus section circumdati
    Aspergillus
    Antifungal susceptibility
    Zootecnia / recursos pesqueiros
    Saúde coletiva
    Química
    Odontología
    Microbiology (medical)
    Microbiology
    Medicina veterinaria
    Medicina iii
    Medicina ii
    Medicina i
    Materiais
    Interdisciplinar
    Farmacia
    Ensino
    Engenharias ii
    Enfermagem
    Ciências biológicas iii
    Ciências biológicas ii
    Ciências biológicas i
    Ciências ambientais
    Ciência de alimentos
    Ciência da computação
    Biotecnología
    Biodiversidade
  • Documents:

  • Cerca a google

    Search to google scholar